戻る Agenda
Advancing the Science of Patient Input: How are WE doing? Multi-Stakeholder Perspective
Session Chair(s)
Pujita Vaidya, MPH
Director, Regulatory Science and Policy
Sanofi, United States
This forum will present current efforts and future opportunities to advance the incorporation of patient input into the medical product lifecycle. A panel of experts will discuss examples of how patient input have informed medical product decisions.
Learning Objective : Discuss current progress by key stakeholders in incorporating patient input into medical product development and regulatory decision-making; Discuss approaches and best practices to collect, analyze, assess quality, and present patient input; Identify opportunities for further enhancing the incorporation of patient input across the medical product lifecycle.
Speaker(s)
Panelist
Michelle Tarver, MD, PhD
FDA, United States
Deputy Center Director for Transformation, CDRH
Panelist
David S. Reasner, PhD
FDA, United States
Director, Division of Clinical Outcome Assessment, OND, CDER
Panelist
Annie Kennedy
EveryLife Foundation for Rare Diseases, United States
Chief of Policy, Advocacy, and Patient Engagement
Panelist
Jessica S. Scott, JD, MD
Legacy Health Strategies , United States
President
Panelist
Robyn T. Carson, MPH
AbbVie, United States
Vice President, Patient-Centered Outcomes Research